Database distributorship geneXplain

Database distributorship

As of July 7, 2016, geneXplain has been granted a world-wide, exclusive and perpetual license to further develop, maintain and commercialize the former BIOBASE databases TRANSFAC®, TRANSPATH® and PROTEOMETM.

TRANSFAC® is the gold standard in transcription regulation, providing information about the involved components (transcription factors, TF, and their genomic binding sites) as well as the largest library of TF binding site models (i.e., positional weight matrices) to be used for the prediction of potential binding sites in DNA sequences.


TRANSPATH® is one of the largest signaling network databases. It has been integrated with the PROTEOME database, but is also available as stand-alone product. Both TRANSFAC and TRANSPATH are valuable resources to fully exploit the capablities of geneXplain’s proprietary upstream analysis implemented in the geneXplain platform.

PROTEOMETM has been a collection of databases about the completre proteomes of different organisms. Its volume HumanPSD (Human Proteome Survey Database) is a comprehensive encyclopedia of the disease associations of human, mouse and rat proteins. Its particular value lies in the identification of known and potential biomarkers.
TRANSFAC® and TRANSPATH® are registered trademarks of QIAGEN, the contents of the mentioned databases are subject to copyright (© Copyright (2016) QIAGEN GmbH).

News

Find history in our archive.

November 15, 2017

Release_note_copper2_big
GeneXplain announces:

geneXplain platform 4.7

October 5-8, 2017

Genexplain gives a talk at the first Congress of Immunology of the Republic of Kazakhstan with the title “Computer analysis of omics data for identification of potential therapeutic targets for autoimmune diseases”.

×